within Pharmacolibrary.Drugs.ATC.N;

model N02AD01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 2.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Pentazocine is a synthetic opioid analgesic that acts as an agonist-antagonist at opioid receptors. It is used for the management of moderate to moderately severe pain. While it was once widely used, its clinical use has declined due to adverse effects and abuse potential, and it is less commonly used today in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for oral administration in healthy adults, based on published data and standard pharmacokinetic modeling assumptions.</p><h4>References</h4><ol><li><p>Thigpen, JC, et al., &amp; Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. <i>European journal of drug metabolism and pharmacokinetics</i> 44(5) 591–609. DOI:<a href=&quot;https://doi.org/10.1007/s13318-019-00552-0&quot;>10.1007/s13318-019-00552-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31006834/&quot;>https://pubmed.ncbi.nlm.nih.gov/31006834</a></p></li><li><p>Fritz, AK, et al., &amp; Edelson, J (1984). Relative bioavailability and pharmacokinetics: a combination of pentazocine and acetaminophen. <i>Journal of pharmaceutical sciences</i> 73(3) 326–331. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600730311&quot;>10.1002/jps.2600730311</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6716239/&quot;>https://pubmed.ncbi.nlm.nih.gov/6716239</a></p></li><li><p>Tegeder, I, et al., &amp; Geisslinger, G (1999). Pharmacokinetics of opioids in liver disease. <i>Clinical pharmacokinetics</i> 37(1) 17–40. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199937010-00002&quot;>10.2165/00003088-199937010-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10451781/&quot;>https://pubmed.ncbi.nlm.nih.gov/10451781</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AD01_1;
